G. Riesco-eizaguirre and P. Santisteban, A perspective view of sodium iodide symporter research and its clinical implications, Eur. J. Endocrinol, vol.155, pp.495-512, 2006.

T. Kogai, K. Taki, and G. A. Brent, Enhancement of sodium/iodide symporter expression in thyroid and breast cancer, Endocr. Relat. Cancer, vol.13, pp.797-826, 2006.

I. L. Wapnir, M. Van-de-rijn, K. Nowels, P. S. Amenta, K. Walton et al., Immunohistochemical profile of the sodium/ iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections, J. Clin. Endocrinol. Metab, vol.88, pp.1880-1888, 2003.

O. Dohan, A. De-la-vieja, V. Paroder, C. Riedel, M. Artani et al., The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance, Endocr. Rev, vol.24, pp.48-77, 2003.

T. Kogai, F. Curcio, S. Hyman, E. M. Cornford, G. A. Brent et al., Induction of follicle formation in long-term cultured normal human thyroid cells treated with thyrotropin stimulates iodide uptake but not sodium/iodide symporter messenger RNA and protein expression, J. Endocrinol, vol.167, pp.125-135, 2000.

C. Riedel, O. Levy, and N. Carrasco, Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin, J. Biol. Chem, vol.276, pp.21458-21463, 2001.

J. Y. Cho, R. Leveille, R. Kao, B. Rousset, A. F. Parlow et al., Hormonal regulation of radioiodide uptake activity and Na+/I-symporter expression in mammary glands, J. Clin. Endocrinol. Metab, vol.85, pp.2936-2943, 2000.

P. L. Welcsh and D. A. Mankoff, Taking up iodide in breast tissue, Nature, vol.406, pp.688-689, 2000.

J. J. Wiltshire, T. M. Drake, L. Uttley, and S. P. Balasubramanian, Systematic Review of Trends in the Incidence Rates of Thyroid Cancer, Thyroid, vol.26, pp.1541-1552, 2016.

C. M. Kitahara and J. A. Sosa, The changing incidence of thyroid cancer, Nat. Rev. Endocrinol, vol.12, pp.646-653, 2016.

S. Zerdoud, A. L. Giraudet, S. Leboulleux, L. Leenhardt, S. Bardet et al., Radioactive iodine therapy, molecular imaging and serum biomarkers for differentiated thyroid cancer: 2017 guidelines of the French Societies of Nuclear Medicine, Endocrine Surgery and Head and Neck Surgery, pp.162-175, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01760914

B. R. Haugen, E. K. Alexander, K. C. Bible, G. M. Doherty, S. J. Mandel et al., American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer, Thyroid, vol.26, pp.1-133, 2015.

E. Kebebew, F. S. Greenspan, O. H. Clark, K. A. Woeber, and A. Mcmillan, Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors, Cancer, vol.103, pp.1330-1335, 2005.

R. Sciuto, L. Romano, S. Rea, F. Marandino, I. Sperduti et al., Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution, Ann. Oncol, vol.20, pp.1728-1735, 2009.

F. Pacini and M. G. Castagna, Approach to and treatment of differentiated thyroid carcinoma, Med. Clin. North Am, vol.96, pp.369-383, 2012.

M. Xing, B. R. Haugen, and M. Schlumberger, Progress in molecular-based management of differentiated thyroid cancer, Lancet, vol.381, pp.1058-1069, 2013.

A. Schmidt, L. Iglesias, M. Klain, F. Pitoia, and M. J. Schlumberger, Radioactive iodinerefractory differentiated thyroid cancer: an uncommon but challenging situation, Arch. Endocrinol. Metab, vol.61, pp.81-89, 2017.

I. J. Nixon, M. M. Whitcher, F. L. Palmer, R. M. Tuttle, A. R. Shaha et al., The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland, Thyroid, vol.22, pp.884-889, 2012.

C. Durante, N. Haddy, E. Baudin, S. Leboulleux, D. Hartl et al., Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy, J. Clin. Endocrinol. Metab, vol.91, pp.2892-2899, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00176664

R. J. Robbins, Q. Wan, R. K. Grewal, R. Reibke, M. Gonen et al., Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning, J. Clin. Endocrinol. Metab, vol.91, pp.498-505, 2006.

T. Ibrahimpasic, R. Ghossein, J. P. Shah, and I. Ganly, Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects, Thyroid, vol.29, pp.311-321, 2019.

V. Lazar, J. M. Bidart, B. Caillou, C. Mahe, L. Lacroix et al., Expression of the Na+/I-symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes, J. Clin. Endocrinol. Metab, vol.84, pp.3228-3234, 1999.

D. Mirebeau-prunier, S. Guyetant, P. Rodien, B. Franc, O. Baris et al., Decreased expression of thyrotropin receptor gene suggests a high-risk subgroup for oncocytic adenoma, Eur. J. Endocrinol, vol.150, pp.269-276, 2004.

J. Nagarajah, A. L. Ho, R. M. Tuttle, W. A. Weber, and R. K. Grewal, Correlation of BRAFV600E mutation and glucose metabolism in thyroid Cancer patients: an (1)(8) F-FDG PET study, J. Nucl. Med, vol.56, pp.662-667, 2015.

, Cancer genome Atlas Research, integrated genomic characterization of papillary thyroid carcinoma, Cell, vol.159, pp.676-690, 2014.

J. A. Fagin and S. A. Wells, Biologic and clinical perspectives on thyroid Cancer, N. Engl. J. Med, vol.375, p.2307, 2016.

M. H. Tesselaar, T. Crezee, I. Schuurmans, D. Gerrits, J. Nagarajah et al., Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer, J. Nucl. Med, vol.59, pp.780-786, 2018.

W. G. Kim, E. Y. Kim, T. Y. Kim, J. S. Ryu, S. J. Hong et al., Redifferentiation therapy with 13-cis retinoic acids in radioiodine-resistant thyroid cancer, Endocr. J, vol.56, pp.105-112, 2009.

C. M. Hong and B. C. Ahn, Redifferentiation of radioiodine refractory differentiated thyroid Cancer for reapplication of I-131 therapy, Front. Endocrinol. (Lausanne), vol.8, p.260, 2017.

F. Courbon, S. Zerdoud, D. Bastie, F. Archambaud, M. Hoff et al., Defective efficacy of retinoic acid treatment in patients with metastatic thyroid carcinoma, Thyroid, vol.16, pp.1025-1031, 2006.

M. Malehmir, V. Haghpanah, B. Larijani, S. Ahmadian, K. Alimoghaddam et al., Multifaceted suppression of aggressive behavior of thyroid carcinoma by all-trans retinoic acid induced re-differentiation, Mol. Cell. Endocrinol, vol.348, pp.260-269, 2012.

S. Jang, X. M. Yu, S. Odorico, M. Clark, R. Jaskula-sztul et al., Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiation, Cancer Gene Ther, vol.22, pp.410-416, 2015.

A. L. Ho, R. K. Grewal, R. Leboeuf, E. J. Sherman, D. G. Pfister et al., Selumetinibenhanced radioiodine uptake in advanced thyroid cancer, N. Engl. J. Med, vol.368, pp.623-632, 2013.

S. M. Rothenberg, D. G. Mcfadden, E. L. Palmer, G. H. Daniels, and L. J. Wirth, Redifferentiation of iodine-refractory BRAF V600E-mutant metastatic papillary thyroid cancer with dabrafenib, Clin. Cancer Res, vol.21, pp.1028-1035, 2015.

G. Segala, M. David, P. Medina, M. C. Poirot, N. Serhan et al., Nat. Commun, vol.8, p.1903, 2017.

S. Silvente-poirot, F. Dalenc, and M. Poirot, The effects of cholesterol-derived oncometabolites on nuclear receptor function in Cancer, Cancer Res, vol.78, pp.4803-4808, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02380550

M. Poirot and S. Silvente-poirot, The tumor-suppressor cholesterol metabolite, dendrogenin A, is a new class of LXR modulator activating lethal autophagy in cancers, Biochem. Pharmacol, vol.153, pp.75-81, 2018.

P. Medina, M. R. Paillasse, G. Segala, M. Voisin, L. Mhamdi et al., Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties, Nat. Commun, vol.4, p.1840, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00823974

S. Silvente-poirot, G. Segala, M. C. Poirot, and M. Poirot, Ligand-dependent transcriptional induction of lethal autophagy: a new perspective for cancer treatment, Autophagy, vol.14, pp.555-557, 2018.

P. Medina, M. R. Paillasse, B. Payre, S. Silvente-poirot, and M. Poirot, Synthesis of new alkylaminooxysterols with potent cell differentiating activities: identification of leads for the treatment of cancer and neurodegenerative diseases, J. Med. Chem, vol.52, pp.7765-7777, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00519151

F. Dalenc, M. Poirot, and S. Silvente-poirot, Dendrogenin a: a mammalian metabolite of cholesterol with tumor suppressor and neurostimulating properties, Curr. Med. Chem, vol.22, pp.3533-3549, 2015.

M. Poirot and S. Silvente-poirot, When cholesterol meets histamine, it gives rise to dendrogenin A: a tumour suppressor metabolite, Biochem. Soc. Trans, vol.44, pp.631-637, 2016.

S. Silvente-poirot, P. Medina, M. Record, and M. Poirot, From tamoxifen to dendrogenin A: the discovery of a mammalian tumor suppressor and cholesterol metabolite, Biochimie, vol.130, pp.109-114, 2016.

S. J. Weiss, N. J. Philp, and E. F. Grollman, Iodide transport in a continuous line of cultured cells from rat thyroid, Endocrinology, vol.114, pp.1090-1098, 1984.

S. Holbeck, J. Chang, A. M. Best, A. L. Bookout, D. J. Mangelsdorf et al., Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions, Mol. Endocrinol, vol.24, pp.1287-1296, 2010.

M. Saiselet, S. Floor, M. Tarabichi, G. Dom, A. Hebrant et al., Thyroid cancer cell lines: an overview, Front. Endocrinol, p.133, 2012.

M. Huang, R. K. Batra, T. Kogai, Y. Q. Lin, J. M. Hershman et al., Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer, Cancer Gene Ther, vol.8, pp.612-618, 2001.

E. Kebebew, J. Weng, J. Bauer, G. Ranvier, O. H. Clark et al., The prevalence and prognostic value of BRAF mutation in thyroid cancer, Ann. Surg, vol.246, pp.466-470, 2007.

M. Korach-andre and J. A. Gustafsson, Liver X receptors as regulators of metabolism, Biomol. Concepts, vol.6, pp.177-190, 2015.

Y. Miao, W. Wu, Y. Dai, L. Maneix, B. Huang et al., Liver X receptor beta controls thyroid hormone feedback in the brain and regulates browning of subcutaneous white adipose tissue, Proc. Natl. Acad. Sci. U S A, vol.112, pp.14006-14011, 2015.

M. Bauriaud-mallet, Journal of Steroid Biochemistry and Molecular Biology, vol.192, p.105390, 2019.